Recordati Rare Diseases Inc. today announced the presentation of real-world data that build upon the safety data of sutimlimab, an FDA-approved therapy for hemolysis in adults with cold agglutinin ...
ProAmpac, a global innovator in flexible packaging and material science, announced today that it has signed a definitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback